Coleman Mark (CIK 0001658379)

Latest company ownership

Shares held
14,600
Last filed at
May 29, 2024
Confidence Score
51.6
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 8, 2025 Sep 9, 2025 Axsome Therapeutics, Inc. Director Buy 65.0 +1,575 0.35% ✗ $200.5K
May 27, 2025 May 29, 2025 Axsome Therapeutics, Inc. Director Sell 42.5 -7,500 -1.64% ✓ $783.4K
May 20, 2025 May 20, 2025 Axsome Therapeutics, Inc. Director Sell 30.0 -3,000 -0.65% ✗ $322.5K
May 28, 2024 May 29, 2024 Axsome Therapeutics, Inc. Director Sell 7.5 -10,497 -41.83% ✓ $789.1K
Sep 15, 2023 Sep 15, 2023 Axsome Therapeutics, Inc. Director Sell 27.5 -29,588 -6.45% ✓ $2.2M
Nov 18, 2021 Nov 22, 2021 Axsome Therapeutics, Inc. Director Buy 65.0 +1,430 0.34% ✗ $50.2K
May 12, 2021 May 13, 2021 Axsome Therapeutics, Inc. Director Buy 56.3 +500 0.12% ✗ $29.1K
Jun 29, 2020 Jun 30, 2020 Axsome Therapeutics, Inc. Director Buy 60.0 +650 0.16% ✗ $51K
Jun 25, 2019 Jun 27, 2019 Axsome Therapeutics, Inc. Director Buy 85.0 +16,200 2.46% ✗ $374.3K
May 13, 2019 May 15, 2019 Axsome Therapeutics, Inc. Director Buy 72.5 +4,650 0.71% ✗ $99.7K
Mar 19, 2019 Mar 21, 2019 Axsome Therapeutics, Inc. Director Buy 72.5 +5,100 0.79% ✗ $62.1K